Pharmacotherapy for bipolar depression: An economic assessment

Charles L. Bowden, Anupama A. Krishnan

Research output: Contribution to journalReview articlepeer-review

17 Scopus citations


Bipolar disorder (BPD) is a common, severe and recurrent mood disorder associated with high rates of comorbidities, suicide, dysfunction and a high socio-economic burden. Although the management of BPD has traditionally focused on the acute treatment of mania, the chronic nature of BPD necessitates long-term maintenance treatment. Bipolar depression is the predominant abnormal affective pole and causes greater disability and economic burden than mania. Maintenance pharmacotherapy can reduce rates of future episodes, and subsequently, the associated risks, functional disability and economic burden of bipolar illness. 2004

Original languageEnglish (US)
Pages (from-to)1101-1107
Number of pages7
JournalExpert Opinion on Pharmacotherapy
Issue number5
StatePublished - May 2004


  • Bipolar depression
  • Bipolar disorder
  • Maintenance treatment
  • Pharmacotherapy
  • Phrmacoeconomics

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)


Dive into the research topics of 'Pharmacotherapy for bipolar depression: An economic assessment'. Together they form a unique fingerprint.

Cite this